8-K/A - Voyager Therapeutics, Inc. (0001640266) (Filer)
Published . Updated .
Key takeaways
- 8-K/A - Voyager Therapeutics filed an 8-K with the SEC on Nov 18 (a notice of a material company event).
- Exposed: VYGR
- Market reaction: price tracking starts with the next trading session.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest and never sell or share it. See our privacy policy.
8-K/A - Voyager Therapeutics filed an 8-K with the SEC on Nov 18 (a notice of a material company event).
Directly affected
- VYGR Voyager Therapeutics-14.2% 12d
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that Voyager Therapeutics belongs to, so it often moves with news about it.
- AMGN Amgen+15.9% 30d
Amgen is a peer of Voyager Therapeutics in biological products, (no diagnostic substances); rivals often move on the same news.
- GILD Gilead Sciences+16.4% 30d
Gilead Sciences is a peer of Voyager Therapeutics in biological products, (no diagnostic substances); rivals often move on the same news.
- MRNA Moderna+22.4% 30d
Moderna is a peer of Voyager Therapeutics in biological products, (no diagnostic substances); rivals often move on the same news.
- ARGX argenx SE-11.9% 9d
argenx SE is a peer of Voyager Therapeutics in biological products, (no diagnostic substances); rivals often move on the same news.
- RVMD Revolution Medicines
Revolution Medicines is a peer of Voyager Therapeutics in biological products, (no diagnostic substances); rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| VYGR | +1.80% | -2.99% | base | after close | after close | after close | after close |
| XLV | +3.66% | +3.71% | base | after close | after close | after close | after close |
| AMGN | +5.25% | +4.18% | base | after close | after close | after close | after close |
| GILD | -0.60% | -0.81% | base | after close | after close | after close | after close |
| MRNA | +17.58% | +9.45% | base | after close | after close | after close | after close |
| ARGX | +4.21% | +1.05% | base | after close | after close | after close | after close |
| RVMD | +10.32% | +4.32% | base | after close | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Filed: 2026-11-18 AccNo: 0001193125-26-467226 Size: 247 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
The price since 18 Nov 2026: Voyager Therapeutics (VYGR) versus the S&P 500
| Company | When | Move | Status |
|---|---|---|---|
| AMGN | three days earlier | +4.18% | final price |
| AMGN | five days earlier | +5.25% | final price |
| ARGX | three days earlier | +1.05% | final price |
| ARGX | five days earlier | +4.21% | final price |
| GILD | three days earlier | -0.81% | final price |
| GILD | five days earlier | -0.60% | final price |
| MRNA | three days earlier | +9.45% | final price |
| MRNA | five days earlier | +17.58% | final price |
| RVMD | three days earlier | +4.32% | final price |
| RVMD | five days earlier | +10.32% | final price |
| Voyager Therapeutics (VYGR) | three days earlier | -2.99% | final price |
| Voyager Therapeutics (VYGR) | five days earlier | +1.80% | final price |
| XLV | three days earlier | +3.71% | final price |
| XLV | five days earlier | +3.66% | final price |
Congressional trades in the stocks in this story
- Rep. David J. Taylor sold Amgen (AMGN), worth $1,001 - $15,000 on 3 Nov 2026. That is 15 days before publication. Filed 12 Nov 2026. View the filing.
- Sen. Sheldon Whitehouse sold Amgen (AMGN) (held by a spouse), worth $15,001 - $50,000 on 15 Oct 2026. That is 34 days before publication. Filed 2 Nov 2026. View the filing.
- Rep. David J. Taylor bought Amgen (AMGN), worth $1,001 - $15,000 on 22 Sep 2026. That is 57 days before publication. Filed 1 Oct 2026. View the filing.
- Rep. Gilbert Cisneros bought Moderna (MRNA), worth $1,001 - $15,000 on 20 Oct 2026. That is 29 days before publication. Filed 10 Nov 2026. View the filing.
- Rep. Maria Elvira Salazar sold Moderna (MRNA), worth $1,001 - $15,000 on 24 Sep 2026. That is 55 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Moderna (MRNA) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 75 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Gilbert Cisneros bought Argenx Se (ARGX), worth $1,001 - $15,000 on 27 Oct 2026. That is 22 days before publication. Filed 10 Nov 2026. View the filing.
- Rep. Gilbert Cisneros bought Argenx Se (ARGX), worth $1,001 - $15,000 on 15 Oct 2026. That is 34 days before publication. Filed 10 Nov 2026. View the filing.
- Rep. Gilbert Cisneros bought Argenx Se (ARGX), worth $15,001 - $50,000 on 14 Oct 2026. That is 35 days before publication. Filed 10 Nov 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who gains and who loses around Voyager Therapeutics (VYGR)
Companies mentioned with this story
- VYGR Voyager Therapeutics
For “8-K/A - Voyager Therapeutics, Inc. (0001640266) (Filer),” Voyager Therapeutics (VYGR) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> VYGR
How “8-K/A - Voyager Therapeutics, Inc. (0001640266) (Filer)” reaches Voyager Therapeutics (VYGR)
“8-K/A - Voyager Therapeutics, Inc. (0001640266) (Filer)” (18 Nov 2026) reaches Voyager Therapeutics (VYGR) through this story.
Voyager Therapeutics (VYGR) is on the page because SEC 8-K filing -> direct issuer disclosure -> VYGR
The price range for Voyager Therapeutics (VYGR), and the dates in the story
VYGR traded between 1.68 and 2.29 across 12 sessions. The latest close on file is 1.88.
How strong the case is around Voyager Therapeutics (VYGR)
14 out of 100
“8-K/A - Voyager Therapeutics, Inc. (0001640266) (Filer)” scores 14 out of 100. The score uses 1 source, and 1 linked company.